Therapeutic Potential for Cytokine Antagonists: Thalidomide and Pentoxifylline in Hansen’s Disease
Cytokine antagonists are a group of drugs defined by their actions on specific cytokines. Cytokine antagonists can inhibit action of cytokines by acting directly on receptors, by affecting production of cytokines or by binding to cytokines and preventing their subsequent action. Recent evidence sugg...
Saved in:
Main Author: | Theresa C Peterson |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1995-01-01
|
Series: | Canadian Journal of Infectious Diseases |
Online Access: | http://dx.doi.org/10.1155/1995/503276 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cytokines as Therapeutic Targets for the Gastrointestinal Manifestations of Scleroderma
by: Jennifer M Raoul, et al.
Published: (2004-01-01) -
Treatment with perilesional injections of pentoxifylline in patients with Peyronie's disease improves the therapeutic effect of oral and topical antioxidant therapy
by: Gianni Paulis, et al.
Published: (2025-02-01) -
Immunohistochemical Study of Nerve Growth Factor Expression in Hansen’s Disease
by: Fatma Lubna, et al.
Published: (2024-12-01) -
Hypertrophic Neuropathy Secondary to Hansen's Disease. A Case Report
by: María Octavina Rodríguez Roque, et al.
Published: (2016-08-01) -
Modulation of Cytokine and Cytokine Receptor/Antagonist by Treatment with Doxycycline and Tetracycline in Patients with Dengue Fever
by: J. E. Z. Castro, et al.
Published: (2011-01-01)